LDS/Medical Tests/Thyroxine Binding Globulin

Thyroxine Binding Globulin

Thyroxine binding globulin, also known as thyroid binding globulin (TBG), is an acidic glycoprotein that has a high binding affinity to thyroxine. It is one of three well-known transporters of both thyroxine (T4) and 3,5,3-triiodothyronine (T3). Other thyroxine carrier proteins are albumin and transthyretin. TBG has a high affinity for the thyroid hormones and is therefore the chief carrier protein. In healthy subjects, less than 0.05% of total circulating T4 is unbound (free). 70-75% of T4 is bound to TBG.

When TBG levels are altered, total T4 levels are altered and free T4 levels are relatively unchanged. Abnormal T4 levels may signify either an abnormality in thyroid function or a variation in TBG. Therefore, free T4 concentration will correlate more closely to clinical thyroid status. Free T4, T4, and T3 should be analyzed along with TBG to assess true thyroid status. The TBG concentration indicates whether an abnormally high or low total thyroid level is offset with a parallel increase or decrease in TBG.

Elevated TBG levels are seen in pregnancy, use of oral contraceptives, estrogen therapy, and in liver diseases. During pregnancy, TBG levels are doubled and remain so until term. Several weeks postpartum, TBG levels return to pre-pregnancy levels. Congenital TBG increase has an X-linked mode of inheritance; these patients have normal free T4. Estimated incidence is 1 in 40,000. Decreased TBG levels are seen in steroid use, liver disease, and nephrotic syndrome.

  • Aid in diagnosis and treatment of thyroid disorders or disease
  • Evaluation of descrepancy between total thyroid hormone levels and thyroid metabolic status, most commonly with oral contraceptive use or pregnancy.
  • Differential diagnosis of thyroid disease with elevated total T4 and normal levels of free T4
  • As an aid in diagnosis of familial dysalbuminemic hyperthyroxinemia and other forms of protein abnormalities

Increased in:

  • Acute intermittent porphyria
  • Pregnancy
  • Oral contraceptives
  • Estrogen therapy
  • Acute infectious hepatitis
  • Hypothyroidism
  • Lymphocytic thyroiditis
  • Some drugs such as clofibrate, perphenazine, methadone, heroine

Decreased in:

  • Anabolic steroids (androgens)
  • Glucocorticoids in large doses
  • Liver disease
  • Nephrotic syndrome
  • Hypoproteinemia
  • Protein malnutrition
  • Malabsorption
  • Major illness
  • Surgical stress
  • Protein-losing enteropathy
  • Active acromegaly
  • Ovarian hypofunction
  • Testosterone producing tumors
  • Genetically low TBG
  • Severe acidosis, large doses of aspirin
  • Some drugs
Group mg/dL mg/L
Cord 3.6–9.6 36–96
4–12 months 3.1–5.6 31–56
1–5 years 2.9–5.4 29–54
5–10 years 2.5–5.0 25–50
10–15 years 2.1–4.6 21–46
Adults
Male 1.2–2.5 12–25
Female 1.4–3.0 14–30
Female on oral contraceptive 1.5–5.5 15–55
Solid-phase, competitive chemiluminescent enzyme immunoassay.

Serum (SST). 

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Thyroxine, Free thyroxine, T3, T3 Uptake, Free Thyroxine Index, Thyroid Stimulating Hormone, Anti-thyroglobulin, Thyroid Peroxidase antibody, Thyroid stimulting hormone receptor antibody.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Mol Med. 2006 Oct;84(10):864-71. [PMID: 16947003]
  • J Clin Endocrinol Metab. 1981 Apr;52(4):657-64. [PMID: 6782114]
  • Horm Res. 1996;45(3-5):128-38. [PMID: 8964571]
  • J Mol Med. 2006 Oct;84(10):864-71. [PMID: 16947003]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757